ABOUT BORA PHARMACEUTICALS
Who We Are
Bora Pharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in complex oral solid dosage (tablet & capsules), biologics, liquids (solutions, suspensions, ophthalmics & nasal sprays), powders, semi-solids (creams, ointments & gels), and sterile injectables for pharmaceutical products for Clinical through Commercial manufacturing and packaging.
Global Presence
Bora owns and operates ten state-of-the-art cGMP manufacturing facilities (Taiwan, Canada, and the US) built to the highest international standards for manufacturing, packaging, R&D, and analytical testing. From these facilities we deliver to more than 100 marketings around the world.
Our Taiwanese facilities are USFDA, MHRA, TFDA, Jordan FDA, and GCC (Gulf Cooperation Council) inspected. Our Mississauga, Canada site is approved by all major regulatory agencies including USFDA, Health Canada, ANVISA, EMEA, PDMA, and the Japanese Ministry of Health. Our last FDA audits have had no 483s.
Commitment to quality
At Bora, we have never compromised on quality, and we never will.
All our manufacturing operations have maintained positive compliance records with many of the world’s leading regulatory agencies, confirming our framework to provide high-quality drug and consumer products.
We operate advanced, electronic quality systems in our laboratories, production areas, quality assurance department, and day-to-day operations and business, thus ensuring Bora’s operational teams have the tools they need to provide the highest levels of proactive and sustainable manufacturing quality.
Bora Pledge
As a future focused CDMO, we know better than most that our own success is shaped by our partners victories. That’s why, when you choose Bora – we make success more certain by following Bora’s 5Ps – Promises, Partnerships, Pride, People, and Progress.
These 5 principles are Bora’s Pledge to our customers.
People
Investing in the best
As an organization, you’re only as good as your people. As a CDMO with ambitious goals, our culture and the caliber of those who represent us is something we must take more seriously than most. For us, success really is personal!
Partnerships
Succeeding with you
With so much on the line, reliable, sustainable partnerships are as important to us as they are to those we work with. Where many CDMOs seem to favor short-term wins, we commit our energies to creating long-term, strategic relationships where success is achieved together.
Promises
Committing to our word
In an industry of uncertainty, there’s absolutely no room for broken promises. Yet, too many CDMOs promise too much, deliver less, and miss deadlines, thereby, eroding confidence and trust. At Bora Pharmaceuticals, we are determined to put this right. When we make promises we keep them, it’s as simple as that.
Pride
Uncompromising about quality
As a business and as people, we take immense pride in what we do. We have to. It’s only by pursuing a deep satisfaction in the quality of our product, the services we’ve provided, or the experience we’ve created that we can be more certain of mutual success.
Progress
Building for the future
Unprecedented regulations, advances, and changes affect today’s pharmaceutical industry, and only the most progressive CDMOs will thrive. At Bora Pharmaceuticals, we’re set on building a business and culture fit for the future. One that’s perpetually enhancing capability and expertise, seeking continuous improvement, and evolving with the long-term needs of our customers.
CONTACT INFORMATION
Bora Pharmaceuticals
7333 Mississauga Rd.
Mississauga, L5N 6L4
CANADA
Phone: 1-844-626-7846
Contact: Anna Hogan, Senior Director Global Marketing
A premier international CDMO, making success more certain.
NEWS
- Bora Pharmaceuticals And Corealis Pharma Forge Strategic Alliance To Deliver Seamless, End-To-End Oral Solid Dose Development
- Bora Pharmaceuticals Marks Five Years In Mississauga, Canada, Strengthening Its Commitment To Onshore And Global CDMO Excellence
- Bora Pharmaceuticals Wins Biotech Company Of The Year Award
- Bora Pharmaceuticals Leverages State-Of-The-Art Isolator Production Line To Scale Supply Of Vital Oncology Therapy
- Bora Pharmaceuticals Wins Canada's Safest New Employer Award
- Bora Pharmaceuticals Introduces High-Potency Liquid Capsule Technology In Taiwan
- Meet With Bora At CPHI Frankfurt 2025
- Bora Pharmaceuticals Announces Multi-Year Expansion For Midwest Manufacturing Site, As Upsher-Smith Entity Split Is Finalized
- Bora Pharmaceuticals Hosted Iowa Governor Kim Reynolds At Subsidiary Upsher-Smith To Discuss U.S. Supply Chain And Regional Collaboration, And Presented At Regional Collaboration – U.S.A Session At Bio Asia
- Bora Pharmaceuticals Adds New Filling Line To Canadian Manufacturing Facility
FEATURED ARTICLES
-
Discover five key factors that drive a seamless and efficient technology transfer, highlighting how a culture of technical expertise, customer focus, and operational flexibility is crucial to success in the CDMO industry.
-
To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.
FEATURED SERVICES
FEATURED BROCHURES
-
Our 87,000 sq. ft. cGMP-certified drug product manufacturing facility, located in Baltimore, Maryland, offers aseptic fill/finish manufacturing of biologics and sterile injectables.
-
By combining deep scientific expertise with cutting-edge technology, we ensure the safety and effectiveness of each formulation through precise control of API release.
-
As a leading CDMO, we specialize in the development and manufacturing of diverse dosage forms for both clinical and commercial applications, driven by a culture of innovation and commitment to quality.